S-WoPEc
 
Scandinavian Working Papers in Economics
HomeAboutSeriesSubject/JEL codesAdvanced Search
HUI Research HUI Working Papers, HUI Research

No 21:
Price and welfare effects of a pharmaceutical substitution reform

David Granlund ()

Abstract: The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a panel of all pharmaceutical product sold in Sweden in 1997--2007. The price reduction due to the reform was estimated to average 10% and was found to be significantly larger for brand name pharmaceuticals than for generics. The results also imply that the reform amplified the effect of generic entry has on brand-name prices by a factor of ten. Results of a demand-estimation imply that the price reductions increased total pharmaceutical consumption by 8% and consumer welfare by SEK 2.7 billion annually.

Keywords: drugs; generic competition; equivalent variarion; demand estimation; (follow links to similar papers)

JEL-Codes: D40; I11; L65; (follow links to similar papers)

29 pages, April 7, 2009

Download Statistics


This paper is published as:
Granlund, David, (2010), 'Price and welfare effects of a pharmaceutical substitution reform', Journal of Health Economics, Vol. 29, December, No. 6, pages 856-865



Questions (including download problems) about the papers in this series should be directed to Helena Nilsson ()
Report other problems with accessing this service to Sune Karlsson () or Helena Lundin ().

Programing by
Design by Joachim Ekebom

Handle: RePEc:hhs:huiwps:0021 This page was generated on 2016-03-01 16:18:35